Erythropoietin protects against diabetes through direct effects on pancreatic β cells
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
A common feature among all forms of diabetes mellitus is a functional β-cell mass insufficient to maintain euglycemia; therefore, the promotion of β-cell growth and survival is a fundamental goal for diabetes prevention and treatment. Evidence has suggested that erythropoietin (EPO) exerts cytoprotective effects on nonerythroid cells. However, the influence of EPO on pancreatic β cells and diabetes has not been evaluated to date. In this study, we report that recombinant human EPO treatment can protect against diabetes development in streptozotocin-induced and db/db mouse models of type 1 and type 2 diabetes, respectively. EPO exerts antiapoptotic, proliferative, antiinflammatory, and angiogenic effects within the islets. Using β-cell–specific EPO receptor and JAK2 knockout mice, we show that these effects of EPO result from direct biological effects on β cells and that JAK2 is an essential intracellular mediator. Thus, promotion of EPO signaling in β cells may be a novel therapeutic strategy for diabetes prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise
Brines, M., & Cerami, A. (2006) · Kidney International · doi:10.1038/sj.ki.5001546 · Cited by 290
Freemark, M. (2002) · Endocrinology · doi:10.1210/en.143.4.1378 · Cited by 258 · cited 2×
“(d) EPO-R belongs to the cytokine class I receptor superfamily and utilizes a similar signal transduction pathway as the receptors for growth hormone and prolactin, knockouts of which show defects in -cell mass and function (Freemark et al., 2002; Liu et al., 2004).”
BackgroundDamen, J., Liu, L., Cutler, R., & Krystal, G. (1993) · Blood · doi:10.1182/blood.v82.8.2296.2296 · Cited by 193 · cited 2×
“…EPO binding to the EPO-R leads to the activation of downstream signaling pathways, including the canonical JAK2–STAT5 pathway, in addition to phosphatidylinositol-3 kinase (PI3K) and Ras–mitogen-activated protein kinase pathways (Damen et al., 1993; He et al., 1993; Quelle et al., 1996).”
BackgroundLactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation
Fujinaka, Y., Takane, K., Yamashita, H., & Vasavada, R. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702607200 · Cited by 92 · cited 2×
“JAK2 is described to function downstream of various growth factors, including growth hormone, prolactin, and placental lactogen, which have all been shown to play an essential role in pancreatic -cell homeostasis (Sorenson and Stout, 1995; Cousin et al., 1999; Fujinaka et al., 2007).”
BackgroundHuman, nonhuman primate, and rat pancreatic islets express erythropoietin receptors1
Fenjves, E. S., Ochoa, M. S., Cabrera, O., Mendez, A. J., Kenyon, N. S., Inverardi, L., & Ricordi, C. (2003) · Transplantation · doi:10.1097/01.tp.0000062862.88375.bd · Cited by 68
Cited by
JAK/STAT – Emerging Players in Metabolism
Dodington, D. W., Desai, H. R., & Woo, M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.11.001 · Cited by 275
Self-citationThe pleiotropic effects of erythropoietin in infection and inflammation
Nairz, M., Sonnweber, T., Schroll, A., Theurl, I., & Weiss, G. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.005 · Cited by 161
“Recent studies have characterized EPO as a potent antiinflammatory cytokine in chronic inflammatory disorders and infectious diseases [25,30,36,41].”
BackgroundHuman β-Cell Proliferation and Intracellular Signaling: Part 3
Stewart, A. F., Hussain, M. A., García-Ocaña, A., Vasavada, R. C., Bhushan, A., Bernal-Mizrachi, E., & Kulkarni, R. N. (2015) · Diabetes · doi:10.2337/db14-1843 · Cited by 142
Dual Role of VAMP8 in Regulating Insulin Exocytosis and Islet β Cell Growth
Zhu, D., Zhang, Y., Lam, P. P. L., Dolai, S., Liu, Y., Cai, E. P., Choi, D., Schroer, S. A., Kang, Y., Allister, E. M., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.001 · Cited by 87
Self-citationShi, S. Y., Luk, C. T., Brunt, J. J., Sivasubramaniyam, T., Lu, S.-Y., Schroer, S. A., & Woo, M. (2014) · Diabetologia · doi:10.1007/s00125-014-3185-0 · Cited by 61
Self-citation
Metadata
- Authors
- Choi, D., Schroer, S. A., Lu, S. Y., Wang, L., Wu, X., Liu, Y., Zhang, Y., Gaisano, H. Y., Wagner, K.-U., Wu, H., Retnakaran, R., & Woo, M.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-12-13
- Volume
- 207
- Issue
- 13
- Pages
- 2831-2842
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2105792913
- Cited by
- 128
- References
- 6
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erythropoietin protects against diabetes through direct effects on pancreatic β cells. https://app.cochat.ai/papers/10.1084/jem.20100665
- The paper
- Choi, D., Schroer, S. A., Lu, S. Y., Wang, L., Wu, X., Liu, Y., Zhang, Y., Gaisano, H. Y., Wagner, K.-U., Wu, H., Retnakaran, R., & Woo, M. (2010). Erythropoietin protects against diabetes through direct effects on pancreatic β cells. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20100665
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.